These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 8583697

  • 1. The protective effect of probucol on adriamycin nephrosis in the rat.
    Futenma A, Miyai H, Iida T, Hara T, Watanabe T, Shiono S, Fukatsu A, Kato K.
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):616-21. PubMed ID: 8583697
    [Abstract] [Full Text] [Related]

  • 2. [The ameliorative effect of probucol on adriamycin (ADR) induced nephrotic rats].
    Shimomura M.
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):165-71. PubMed ID: 7731104
    [Abstract] [Full Text] [Related]

  • 3. [Relationship between glomerular nephrin expression and oxidative stress reaction in rats with adriamycin-induced nephrosis].
    Zhu Y, Lu L.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):56-60. PubMed ID: 19149925
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy.
    Kaul N, Siveski-Iliskovic N, Thomas TP, Hill M, Khaper N, Singal PK.
    Nutrition; 1995 Jan; 11(5 Suppl):551-4. PubMed ID: 8748220
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
    Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S.
    Toxicology; 2006 Feb 01; 218(2-3):164-71. PubMed ID: 16325981
    [Abstract] [Full Text] [Related]

  • 7. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
    Iliskovic N, Singal PK.
    Am J Pathol; 1997 Feb 01; 150(2):727-34. PubMed ID: 9033285
    [Abstract] [Full Text] [Related]

  • 8. Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy.
    Qin XJ, He W, Hai CX, Liang X, Liu R.
    J Appl Toxicol; 2008 Apr 01; 28(3):271-82. PubMed ID: 17582587
    [Abstract] [Full Text] [Related]

  • 9. Exposure to hydrocarbons and renal disease: an experimental animal model.
    Mutti A, Coccini T, Alinovi R, Toubeau G, Broeckaert F, Bergamaschi E, Mozzoni P, Nonclercq D, Bernard A, Manzo L.
    Ren Fail; 1999 Apr 01; 21(3-4):369-85. PubMed ID: 10416216
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy.
    Iliskovic N, Hasinoff BB, Malisza KL, Li T, Danelisen I, Singal PK.
    Mol Cell Biochem; 1999 Jun 01; 196(1-2):43-9. PubMed ID: 10448901
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
    Bulucu F, Oktenli C, Kenar L, Ocal R, Koc B, Inal V, Yamanel L, Yaman H, Sanisoglu YS, Aydin A.
    J Nephrol; 2008 Jun 01; 21(4):576-83. PubMed ID: 18651549
    [Abstract] [Full Text] [Related]

  • 13. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
    El-Demerdash E, Ali AA, Sayed-Ahmed MM, Osman AM.
    Cancer Chemother Pharmacol; 2003 Nov 01; 52(5):411-6. PubMed ID: 12879278
    [Abstract] [Full Text] [Related]

  • 14. Lysophosphatidylcholine molecular species in low density lipoprotein and high density lipoprotein in alloxan-induced diabetic rats: effect of probucol.
    Shi A, Yoshinari M, Iino K, Wakisaka M, Iwase M, Fujishima M.
    Exp Clin Endocrinol Diabetes; 1999 Nov 01; 107(6):337-42. PubMed ID: 10543409
    [Abstract] [Full Text] [Related]

  • 15. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.
    Siveski-Iliskovic N, Kaul N, Singal PK.
    Circulation; 1994 Jun 01; 89(6):2829-35. PubMed ID: 8205698
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G, Imberti L, Rossini M, Morelli C, Carminati C, Cattaneo GM, Bertani T.
    J Clin Invest; 1985 Jan 01; 75(1):94-101. PubMed ID: 4038407
    [Abstract] [Full Text] [Related]

  • 19. Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
    Drukker A, Eddy AA.
    J Am Soc Nephrol; 1998 Feb 01; 9(2):243-51. PubMed ID: 9527400
    [Abstract] [Full Text] [Related]

  • 20. Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.
    Kondo S, Shimizu M, Urushihara M, Tsuchiya K, Yoshizumi M, Tamaki T, Nishiyama A, Kawachi H, Shimizu F, Quinn MT, Lambeth DJ, Kagami S.
    J Am Soc Nephrol; 2006 Mar 01; 17(3):783-94. PubMed ID: 16467449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.